CH235949A - Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylene-sulfonic acid morpholine. - Google Patents

Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylene-sulfonic acid morpholine.

Info

Publication number
CH235949A
CH235949A CH235949DA CH235949A CH 235949 A CH235949 A CH 235949A CH 235949D A CH235949D A CH 235949DA CH 235949 A CH235949 A CH 235949A
Authority
CH
Switzerland
Prior art keywords
sep
amino
benzenesulfonyl
pyridine
sulfonic acid
Prior art date
Application number
Other languages
German (de)
Inventor
Dr. A. Wander Aktiengesellschaft
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Publication of CH235949A publication Critical patent/CH235949A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/46Oxygen atom in position 3 or 5 and nitrogen atom in position 4
    • C07D231/48Oxygen atom in position 3 or 5 and nitrogen atom in position 4 with hydrocarbon radicals attached to said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

       

  Verfahren     zur        Herstellung    von     p-amino-benzolsulfonyl-a-amino-pyridin-Bz-N-          methylensulfosaurem        3lorpholin.     
EMI0001.0006     
  
    Im <SEP> Hauptpatent <SEP> ist <SEP> ein <SEP> Verfahren <SEP> zur
<tb>  Herstellung <SEP> von <SEP> p-amino--benzolsulfonyl-a  amino <SEP> - <SEP> pyridin <SEP> - <SEP> Bz <SEP> - <SEP> N.- <SEP> m-ethylensulfosaurem
<tb>  Hegamethylentetramindurch <SEP> Umsetzung <SEP> der
<tb>  freien <SEP> Säure <SEP> mit <SEP> IlegamMhylentetramin <SEP> be  schrieben.
<tb>  



  Es <SEP> wurde <SEP> nun <SEP> gefunden, <SEP> class <SEP> man <SEP> ein
<tb>  therapeutisch <SEP> ebenso <SEP> wertvolles <SEP> Salz <SEP> erhält.
<tb>  wenn <SEP> man <SEP> p-Amino-benzo1.sulfonyl-a-amino  pyridin-Bz-N-anethylensulfosäure <SEP> auf <SEP> Mor  pholin <SEP> in <SEP> Gegenwart <SEP> eines <SEP> Alkohols <SEP> einwir  ken <SEP> lässt.
<tb>  



  <I>Beispiel:</I>
<tb>  8,71 <SEP> g <SEP> Morpholin <SEP> werden <SEP> in <SEP> <B>100</B> <SEP> cm'
<tb>  Wasser <SEP> ;gelöst <SEP> und <SEP> unter <SEP> Umrühren <SEP> 34,33 <SEP> .g
<tb>  p-Amino-benzol#suIfonyl-,a-amino-pyridin-Bz  N-methylensulfosäure <SEP> eingetragen. <SEP> Die <SEP> ent  standene <SEP> Lösung <SEP> versetzt <SEP> man <SEP> mit <SEP> 200 <SEP> ein'
<tb>  IsoTropyla@lkohol <SEP> und <SEP> lässt <SEP> zur <SEP> Kristallifa  tion, <SEP> gegebenenfalls <SEP> im <SEP> Eisschrank, <SEP> stehen.
<tb>  Die <SEP> in <SEP> Form <SEP> von <SEP> weissen <SEP> feinen <SEP> Nadel-       büscheln abgeschiedenen     Kristalle    geben  einen     Schmelzpunkt    von 173-175  unter       Zersetzung    und zeigen gute Löslichkeit in  Wasser.

   Das     p-amino-benzolsulfonyl-a-amino-          pyridin-Bz-N-m-ethylens\ulfosaure        Morpholin     soll     therapeutisch,        insbesondere    für     Injek-          tionslösungen,    Verwendung finden.



  Process for the preparation of p-amino-benzenesulfonyl-a-aminopyridine-Bz-N-methylensulfosaurem 3lorpholine.
EMI0001.0006
  
    In the <SEP> main patent <SEP> <SEP> is a <SEP> method <SEP> for
<tb> Production <SEP> of <SEP> p-amino - benzenesulfonyl-a amino <SEP> - <SEP> pyridine <SEP> - <SEP> Bz <SEP> - <SEP> N.- <SEP> m -ethylenesulfonic acid
<tb> Hegamethylenetetramine by <SEP> implementation <SEP> der
<tb> free <SEP> acid <SEP> with <SEP> IlegamMhylenetetramine <SEP> described.
<tb>



  <SEP> has now been found <SEP>, <SEP> class <SEP> man <SEP>
<tb> therapeutically <SEP> also <SEP> contains valuable <SEP> salt <SEP>.
<tb> if <SEP> one <SEP> p-Amino-benzo1.sulfonyl-a-amino pyridine-Bz-N-anethylene sulfonic acid <SEP> on <SEP> Morpholine <SEP> in <SEP> presence <SEP> one <SEP> Alcohol <SEP> has an effect <SEP>.
<tb>



  <I> Example: </I>
<tb> 8.71 <SEP> g <SEP> Morpholine <SEP> become <SEP> in <SEP> <B> 100 </B> <SEP> cm '
<tb> water <SEP>; dissolved <SEP> and <SEP> under <SEP> stirring <SEP> 34,33 <SEP> .g
<tb> p-Amino-benzene # sulfonyl-, a-Amino-pyridine-Bz N-methylene sulfonic acid <SEP> entered. <SEP> The <SEP> resulting <SEP> solution <SEP> is set to <SEP>, <SEP> with <SEP> 200 <SEP> '
<tb> IsoTropyla @ alcohol <SEP> and <SEP> leaves <SEP> for <SEP> crystallization, <SEP> if necessary <SEP> in the <SEP> refrigerator, <SEP>.
<tb> The <SEP> crystals deposited in <SEP> form <SEP> of <SEP> white <SEP> fine <SEP> tufts of needles give a melting point of 173-175 with decomposition and show good solubility in water.

   The p-amino-benzenesulfonyl-a-aminopyridine-Bz-N-m-ethylene \ ulfo acid morpholine is intended to be used therapeutically, especially for injection solutions.


    

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von p:-amino- benzolsulfonyl - a - amino - pyridin - Bz - N - methylensulfosaurem Morpholin, dadurch ge- kennzeichnet, PATENT CLAIM: Process for the production of p: -amino- benzenesulfonyl - a - amino - pyridine - Bz - N - methylensulfonic acid morpholine, characterized in that da3 man p-Amino-benzol- sulfonyl - a - amino - pyridin - Bz - N-methylen- sulfosäure in Gegenwart eines Alkohols auf Morpholin. einwirken lässt- Das neue Produkt bildet feine weisse Nadeln, die bei 173-175 unter Zersetzung schmelzen und in Wasser gut löslich sind. that p-amino-benzenesulfonyl-a-amino-pyridine-Bz-N-methylene-sulfonic acid in the presence of an alcohol on morpholine. The new product forms fine white needles which melt at 173-175 with decomposition and are readily soluble in water.
CH235949D 1942-05-02 1942-05-02 Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylene-sulfonic acid morpholine. CH235949A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH235949T 1942-05-02
CH228551T 1943-04-06

Publications (1)

Publication Number Publication Date
CH235949A true CH235949A (en) 1945-05-16

Family

ID=25727228

Family Applications (1)

Application Number Title Priority Date Filing Date
CH235949D CH235949A (en) 1942-05-02 1942-05-02 Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylene-sulfonic acid morpholine.

Country Status (1)

Country Link
CH (1) CH235949A (en)

Similar Documents

Publication Publication Date Title
CH235949A (en) Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylene-sulfonic acid morpholine.
DE638832C (en) Process for the preparation of water-soluble polyazo dyes
DE608667C (en) Process for the preparation of water-soluble zinc compounds of oxymethanesulfinic acid
DE737691C (en) Process for the separation of mixtures of higher homologues of adipic acid
DE588650C (en) Process for the preparation of oxydiphenyl ether carboxylic acids
AT138027B (en) Process for the preparation of 8-oxyquinoline.
DE397813C (en) Process for the preparation of p-dialkylaminoarylphosphinic acids
DE858559C (en) Process for the manufacture of tanning agents
DE919351C (en) Process for the preparation of new derivatives of isonicotinic acid amide
DE397405C (en) Process for the production of artificial tanning agents
AT99681B (en) Process for the preparation of easily soluble salts of quinine.
DE634042C (en) Process for the representation of dyes
DE399741C (en) Process for the preparation of pure 1-nitro-2-methylanthraquinone
DE495103C (en) Process for the preparation of compounds of the ª † -aminoglycomonoaether and their derivatives
AT87715B (en) Process for tanning animal hides.
DE466360C (en) Process for the preparation of salts of 1-methyl-4-isopropylbenzenesulfonic acids and their substitution products
DE613066C (en) Process for the preparation of 8-oxychinaldine
DE924821C (en) Process for the production of therapeutically valuable salts
DE874309C (en) Process for the production of sulfamic acids and their salts
DE968212C (en) Process for the production of guanidides of organic sulfonic acids
AT222644B (en) Process for the preparation of pure 4,4&#39;-dihydroxydiarylalkanes
AT151657B (en) Process for the preparation of formaldehyde sodium sulfoxylates from arsenobenzene compounds.
DE664652C (en) Process for the preparation of pyrene-3, 5-disulfonic acid and its salts
DE752643C (en) Process for making a durable K-strophantine ª †
CH253640A (en) Process for the preparation of 2- (3 &#39;, 5&#39;-dibromo-salicoylamino) -thiazole.